EP1007555A4 - Tropoelastinderivate - Google Patents

Tropoelastinderivate

Info

Publication number
EP1007555A4
EP1007555A4 EP98933366A EP98933366A EP1007555A4 EP 1007555 A4 EP1007555 A4 EP 1007555A4 EP 98933366 A EP98933366 A EP 98933366A EP 98933366 A EP98933366 A EP 98933366A EP 1007555 A4 EP1007555 A4 EP 1007555A4
Authority
EP
European Patent Office
Prior art keywords
derivatives
variants
expression products
hybrid molecules
tropoelastine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP98933366A
Other languages
English (en)
French (fr)
Other versions
EP1007555B1 (de
EP1007555A1 (de
Inventor
Anthony Steven Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sydney filed Critical University of Sydney
Priority to EP08010161A priority Critical patent/EP1978031A3/de
Publication of EP1007555A1 publication Critical patent/EP1007555A1/de
Publication of EP1007555A4 publication Critical patent/EP1007555A4/de
Application granted granted Critical
Publication of EP1007555B1 publication Critical patent/EP1007555B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
EP98933366A 1997-07-18 1998-07-17 Tropoelastinderivate Expired - Lifetime EP1007555B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08010161A EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO811797 1997-07-18
AUPO8117A AUPO811797A0 (en) 1997-07-18 1997-07-18 Tropoelastin derivatives
PCT/AU1998/000564 WO1999003886A1 (en) 1997-07-18 1998-07-17 Tropoelastin derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP08010161A Division EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Publications (3)

Publication Number Publication Date
EP1007555A1 EP1007555A1 (de) 2000-06-14
EP1007555A4 true EP1007555A4 (de) 2003-08-13
EP1007555B1 EP1007555B1 (de) 2008-08-27

Family

ID=3802406

Family Applications (2)

Application Number Title Priority Date Filing Date
EP98933366A Expired - Lifetime EP1007555B1 (de) 1997-07-18 1998-07-17 Tropoelastinderivate
EP08010161A Withdrawn EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP08010161A Withdrawn EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Country Status (10)

Country Link
US (3) US7803577B2 (de)
EP (2) EP1007555B1 (de)
JP (1) JP2001510032A (de)
KR (1) KR100636948B1 (de)
AT (1) ATE406382T1 (de)
AU (1) AUPO811797A0 (de)
CA (1) CA2296841C (de)
DE (1) DE69839939D1 (de)
NZ (1) NZ502026A (de)
WO (1) WO1999003886A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7193043B1 (en) 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
US6903244B1 (en) * 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
EP1945144A4 (de) * 2005-10-19 2012-12-05 Kenton W Gregory Verfahren zur verwendung und herstellung von tropoelastin und tropoelastin-biomaterialien
EP2117620A4 (de) 2006-09-29 2010-12-01 Martin Kean Chong Ng Protoelastin-biomaterialien auf tropoelastin-basis
WO2008058323A1 (en) 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US8808365B2 (en) 2009-01-07 2014-08-19 Martin Kean Chong Ng Chemically and biologically modified medical devices
JP5684154B2 (ja) 2009-03-10 2015-03-11 ザ・ユニバーシティ・オブ・シドニー 注射用生体材料
BR112014007451A2 (pt) 2011-09-30 2017-04-04 Univ Sydney síntese in vivo de fibras elásticas
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
KR20230004965A (ko) 2013-08-13 2023-01-06 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생
CA2996427A1 (en) 2015-09-01 2017-03-09 Allergan Pharmaceuticals International Limited Formation of bone
FR3051191B1 (fr) * 2016-05-13 2020-03-06 Centre National De La Recherche Scientifique Polypeptide derive de la tropoelastine et materiau biocompatible le comprenant
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
US20190275087A1 (en) 2018-03-01 2019-09-12 Allergan Pharmaceuticals International Limited Expansion and differentiation of stem cells
EP3953380A4 (de) 2019-04-12 2023-01-25 Geltor, Inc. Rekombinantes elastin und herstellung davon
WO2020225694A1 (en) 2019-05-03 2020-11-12 Allergan Pharmaceuticals International Limited Scar prevention and/or treatment
MX2022002275A (es) 2019-08-23 2022-06-02 Allergan Pharmaceuticals Int Ltd Tropoelastina para uso en el tratamiento de cicatrices de acne.
EP4076555A1 (de) 2019-12-18 2022-10-26 Allergan Pharmaceuticals International Limited Hybridpolymermaterialie und verwendungen davon
GB2610313B (en) 2020-01-24 2024-07-03 Geltor Inc Animal-free dietary collagen
CN115697427A (zh) * 2020-02-06 2023-02-03 阿勒根制药国际有限公司 组织工程支架
BR112022023209A2 (pt) 2020-05-14 2023-02-07 Allergan Pharmaceuticals Int Ltd Composições compreendendo tropoelastina reticulada ao ácido hialurônico e métodos de uso das mesmas

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014958A1 (en) * 1992-12-22 1994-07-07 The University Of Sydney Synthetic polynucleotides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474851A (en) 1981-10-02 1984-10-02 The University Of Alabama In Birmingham Elastomeric composite material comprising a polypeptide
US5250516A (en) 1986-04-17 1993-10-05 Uab Research Foundation Bioelastomeric materials suitable for the protection of burn areas or the protection of wound repair sites from the occurrence of adhesions
JPH01235472A (ja) 1988-03-16 1989-09-20 Fujitsu Ltd ファクシミリ装置
NZ230375A (en) 1988-09-09 1991-07-26 Lubrizol Genetics Inc Synthetic gene encoding b. thuringiensis insecticidal protein
US5726040A (en) * 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US6451326B2 (en) * 1996-05-02 2002-09-17 Burt D. Ensley Cosmetic compositions
JP2001505539A (ja) * 1996-08-07 2001-04-24 プロテイン・スペシャルティーズ，リミテッド エラスチン及び他の線維状タンパク質由来の自己整列ペプチド
US6489446B1 (en) * 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
AUPO811797A0 (en) * 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US7193043B1 (en) * 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
EP2117620A4 (de) * 2006-09-29 2010-12-01 Martin Kean Chong Ng Protoelastin-biomaterialien auf tropoelastin-basis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014958A1 (en) * 1992-12-22 1994-07-07 The University Of Sydney Synthetic polynucleotides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DEBRA BEDELL-HOGAN ET AL.: "Oxidation, cross-linking, and insolubilization of recombinant tropoelastin by purified Lysyl oxidase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 14, 15 May 1993 (1993-05-15), MD US, pages 10345 - 10350, XP002235105 *
MICHAEL J. FAZIO ET AL.: "Isolation and characterization of human elastin cDNAs, and age-associated variation in elastin gene expression in cultured skin fibroblasts", LABORATORY INVESTIGATION, vol. 58, no. 3, March 1988 (1988-03-01), pages 270 - 277, XP008015156 *
STEPHEN L. MARTIN ET AL.: "Total synthesis and expression in Escherichia coli of a gene encoding human tropoelastin", GENE, vol. 154, 1995, AMSTERDAM NL, pages 159 - 166, XP004042466 *
ZENA INDIK ET AL.: "Production of recombinant human tropoelastin: Characterization and demonstration of immunologic and chemotactic activity", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 280, no. 1, July 1990 (1990-07-01), pages 80 - 86, XP000933577 *

Also Published As

Publication number Publication date
AUPO811797A0 (en) 1997-08-14
EP1007555B1 (de) 2008-08-27
ATE406382T1 (de) 2008-09-15
US20080039397A1 (en) 2008-02-14
CA2296841C (en) 2012-02-21
EP1007555A1 (de) 2000-06-14
KR20010021999A (ko) 2001-03-15
DE69839939D1 (de) 2008-10-09
NZ502026A (en) 2002-03-01
EP1978031A3 (de) 2008-10-22
KR100636948B1 (ko) 2006-10-19
WO1999003886A1 (en) 1999-01-28
JP2001510032A (ja) 2001-07-31
US8710015B2 (en) 2014-04-29
US7803577B2 (en) 2010-09-28
CA2296841A1 (en) 1999-01-28
US20110021752A1 (en) 2011-01-27
US20120130046A1 (en) 2012-05-24
EP1978031A2 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
EP1007555A4 (de) Tropoelastinderivate
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
ATE418547T1 (de) Zwischenprodukte zur herstellung von anti- thrombotischen 4h-cyclopenta-1,3-dioxol-derivaten
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
DE69806831D1 (de) Dithiolan Derivate, deren Herstellung und deren Heileffekt
PE14199A1 (es) Agonistas de 5-ht1f
PT823889E (pt) Derivados de 1,3-propanodiol como compostos bioactivos
CY1111504T1 (el) Αζαδικυκλοαλκανια ως ρυθμιστες του ccr5
ES2158115T3 (es) Derivados de histidina y homohistidina como inhibidores de la farnesiltransferasa de proteinas.
HN1996000017A (es) Isotiazolonas
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
PT971717E (pt) Amino-acucar citotoxico e derivados de acucar afins de indolopirrolocarbazois
MX9601994A (es) Profarmacos de derivados de paclitaxel.
DE59909607D1 (de) Tan-1057 derivate
ID25478A (id) Agonis 5-ht1f
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
ATE494375T1 (de) Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen
BR9807312A (pt) Derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos
PT951471E (pt) Inibidores cicloalquilo de farnesiltransferase de proteinas
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
BR9911356A (pt) Sìntese de benzo[f]quinolinonas
IT1289852B1 (it) Prodotto cosmetico per il trattamento delle smagliature
ECSP972339A (es) Inhibidores de cicloalquilo de la farnesil transferasa de las proteinas

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000204

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030627

17Q First examination report despatched

Effective date: 20040209

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69839939

Country of ref document: DE

Date of ref document: 20081009

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090127

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20090528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090731

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090731

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69839939

Country of ref document: DE

Representative=s name: WEICKMANN & WEICKMANN PATENT- UND RECHTSANWAEL, DE

Ref country code: DE

Ref legal event code: R082

Ref document number: 69839939

Country of ref document: DE

Representative=s name: WEICKMANN & WEICKMANN PATENTANWAELTE - RECHTSA, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 69839939

Country of ref document: DE

Owner name: ELASTAGEN PTY LTD, EVELEIGH, AU

Free format text: FORMER OWNER: THE UNIVERSITY OF SYDNEY, SYDNEY, NEUSUEDWALES/NEW SOUTH WALES, AU

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20170518 AND 20170524

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20170724

Year of fee payment: 20

Ref country code: GB

Payment date: 20170719

Year of fee payment: 20

Ref country code: FR

Payment date: 20170724

Year of fee payment: 20

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

Owner name: ELASTAGEN PTY LTD, AU

Effective date: 20170929

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69839939

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20180716

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20180716